Emergency department management of community-acquired methicillin-resistant Staphylococcus aureus

Brendan J Kilbane1, Sally L Reynolds

  • 1Division of Pediatric Emergency Medicine, Rainbow Babies and Children's Hospital, Case Western Reserve University, School of Medicine, Cleveland, OH, USA. bkilbane@childrensmemorial.org

Pediatric Emergency Care
|February 19, 2008
PubMed

Insights

Emerging antibiotic-resistant Staphylococcus aureus strains complicate emergency department care for infections like pneumonia and sepsis. Emergency providers must recognize these resistant bacteria and know effective antibiotic treatments.

Area of Science:

  • Infectious Diseases
  • Emergency Medicine
  • Microbiology

Background:

  • Staphylococcus aureus causes common emergency department illnesses such as skin infections, pneumonia, and sepsis.
  • The rise of antibiotic-resistant strains, particularly community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA), challenges traditional treatment protocols.
  • Effective management requires awareness of resistant bacterial prevalence and appropriate therapeutic strategies.

Purpose of the Study:

  • To inform emergency care providers about the increasing prevalence of antibiotic-resistant Staphylococcus aureus.
  • To outline the clinical characteristics of infections caused by these resistant strains.
  • To review effective antibiotic options for treating Staphylococcus aureus infections in the emergency department.

Main Methods:

  • Literature review of Staphylococcus aureus epidemiology and antibiotic resistance patterns.
  • Analysis of clinical presentations and management strategies for emergency department patients.
  • Synthesis of current evidence on effective antibiotic therapies.

Main Results:

  • Antibiotic resistance in Staphylococcus aureus is a growing concern in community and hospital settings.
  • Resistant strains are associated with severe infections, including pneumonia, sepsis, and complicated skin and soft tissue infections.
  • Specific antibiotic regimens are recommended for treating resistant Staphylococcus aureus infections.

Conclusions:

  • Emergency physicians must be vigilant regarding Staphylococcus aureus antibiotic resistance.
  • Understanding infection characteristics and current treatment guidelines is crucial for optimal patient outcomes.
  • Prompt and appropriate antibiotic selection is key to managing these challenging infections.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...